Literature DB >> 12168770

Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptors.

J D Lünemann1, F Buttgereit, R Tripmacher, C G Baerwald, G R Burmester, A Krause.   

Abstract

Previous studies demonstrated that the adaptive response to stressors and inflammatory signals involves the activation of the autonomous [corrected] nervous system. Catecholamines have been shown to modulate the activity of various immune effector cells directly via membrane adrenergic receptors. Here, we investigated immediate effects of norepinephrine on energy metabolism of immune cells. Norepinephrine inhibits oxygen consumption of human peripheral blood mononuclear cells at concentrations that are relevant to its physiological range. The beta-adrenoreceptor antagonist propranolol, but not the alpha-adrenoreceptor antagonist phentolamine reversed the norepinephrine induced inhibition in quiescent cells. Conversely, phentolamine but not propranolol is capable of blocking norepinephrine mediated effects in mitogen activated human peripheral blood mononuclear cells. Our data indicate that the sensitization of alpha- and beta-adrenoreceptors on immune cells is differentially regulated, and that these processes depend on the activation state of these cells. These findings have important implications for the understanding of stress-induced suppression of immune function and may contribute to the elucidation of the pathogenesis of immunologically mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12168770     DOI: 10.1023/a:1014768909442

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  10 in total

1.  Inotropes and vasopressors: more than haemodynamics!

Authors:  Hendrik Bracht; Enrico Calzia; Michael Georgieff; Joel Singer; Peter Radermacher; James A Russell
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Pharmacological optimization of tissue perfusion.

Authors:  N Mongardon; A Dyson; M Singer
Journal:  Br J Anaesth       Date:  2009-05-21       Impact factor: 9.166

Review 3.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI.

Authors:  Nathaniel B Bone; Zhongyu Liu; Jean-Francois Pittet; Jaroslaw W Zmijewski
Journal:  J Leukoc Biol       Date:  2016-10-12       Impact factor: 4.962

5.  Effect of SOD-1 over-expression on myocardial function during resuscitated murine septic shock.

Authors:  Katja Baumgart; Vladislava Simkova; Florian Wagner; Sandra Weber; Michael Georgieff; Peter Radermacher; Gerd Albuszies; Eberhard Barth
Journal:  Intensive Care Med       Date:  2008-10-15       Impact factor: 17.440

Review 6.  Critical illness and flat batteries.

Authors:  Mervyn Singer
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

7.  No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea.

Authors:  Izabela Grabska-Kobylecka; Andrzej Kobylecki; Piotr Bialasiewicz; Maciej Krol; Golsa Ehteshamirad; Marek Kasielski; Dariusz Nowak
Journal:  J Negat Results Biomed       Date:  2008-11-25

8.  Sepsis therapy: what's the best for the mitochondria?

Authors:  Florian Wagner; Peter Radermacher; Michael Georgieff; Enrico Calzia
Journal:  Crit Care       Date:  2008-08-06       Impact factor: 9.097

Review 9.  Immune response in severe infection: could life-saving drugs be potentially harmful?

Authors:  Maja Surbatovic; Jasna Jevdjic; Milic Veljovic; Nada Popovic; Dragan Djordjevic; Sonja Radakovic
Journal:  ScientificWorldJournal       Date:  2013-09-30

10.  Azurocidin-induced inhibition of oxygen metabolism in mitochondria is antagonized by heparin.

Authors:  Liang Wang; Zhiyong Liu; Zhe Dong; Jieyi Pan; Xiaochun Ma
Journal:  Exp Ther Med       Date:  2014-08-29       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.